XML 19 R8.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
OPERATING ACTIVITIES:    
Net income $ 15,118 $ 10,623
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 30,779 30,550
Stock-based compensation 3,285 3,076
Amortization of deferred commissions 9,060 8,467
Provision for credit losses 2,027 675
Deferred income taxes (960) (2,634)
Loss on equity method investments 150 330
Change in fair value of non-marketable equity investments 0 (45)
Other (1,205) (603)
Changes in operating assets and liabilities:    
Accounts and unbilled receivables (4,744) (7,230)
Prepaid royalties 962 (1,684)
Other prepaid expenses and other current assets (177) (817)
Deferred commissions (9,138) (9,583)
Other assets 143 336
Accounts payable and accrued expenses (8,371) (736)
Accrued royalties 1,266 1,419
Deferred revenue (1,183) 3,554
Net cash provided by operating activities 46,500 50,158
INVESTING ACTIVITIES:    
Business combinations, net of cash acquired 0 (6,621)
Proceeds from maturities of marketable securities 46,170 19,000
Purchases of marketable securities (51,531) (38,235)
Proceeds from sale of non-marketable equity investments 765 45
Payments associated with capitalized software development (20,107) (19,552)
Purchases of property and equipment (1,198) (1,854)
Net cash used in investing activities (25,901) (47,217)
FINANCING ACTIVITIES:    
Taxes paid related to net settlement of equity awards (932) (817)
Repurchases of common stock 0 (1,648)
Payment of cash dividends (2,551) (2,301)
Net cash used in financing activities (3,483) (4,766)
Effect of exchange rate changes on cash and cash equivalents 40 (75)
Net increase (decrease) in cash and cash equivalents 17,156 (1,900)
Cash and cash equivalents at beginning of period 40,333 46,023
Cash and cash equivalents at end of period $ 57,489 $ 44,123